Cargando…
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529863/ https://www.ncbi.nlm.nih.gov/pubmed/34674735 http://dx.doi.org/10.1186/s12967-021-03094-9 |
| _version_ | 1784586553091162112 |
|---|---|
| author | Perrone, Francesco Piccirillo, Maria Carmela Ascierto, Paolo Antonio Salvarani, Carlo Parrella, Roberto Marata, Anna Maria Popoli, Patrizia Ferraris, Laurenzia Marrocco-Trischitta, Massimiliano M. Ripamonti, Diego Binda, Francesca Bonfanti, Paolo Squillace, Nicola Castelli, Francesco Muiesan, Maria Lorenza Lichtner, Miriam Calzetti, Carlo Salerno, Nicola Duccio Atripaldi, Luigi Cascella, Marco Costantini, Massimo Dolci, Giovanni Facciolongo, Nicola Cosimo Fraganza, Fiorentino Massari, Marco Montesarchio, Vincenzo Mussini, Cristina Negri, Emanuele Alberto Botti, Gerardo Cardone, Claudia Gargiulo, Piera Gravina, Adriano Schettino, Clorinda Arenare, Laura Chiodini, Paolo Gallo, Ciro |
| author_facet | Perrone, Francesco Piccirillo, Maria Carmela Ascierto, Paolo Antonio Salvarani, Carlo Parrella, Roberto Marata, Anna Maria Popoli, Patrizia Ferraris, Laurenzia Marrocco-Trischitta, Massimiliano M. Ripamonti, Diego Binda, Francesca Bonfanti, Paolo Squillace, Nicola Castelli, Francesco Muiesan, Maria Lorenza Lichtner, Miriam Calzetti, Carlo Salerno, Nicola Duccio Atripaldi, Luigi Cascella, Marco Costantini, Massimo Dolci, Giovanni Facciolongo, Nicola Cosimo Fraganza, Fiorentino Massari, Marco Montesarchio, Vincenzo Mussini, Cristina Negri, Emanuele Alberto Botti, Gerardo Cardone, Claudia Gargiulo, Piera Gravina, Adriano Schettino, Clorinda Arenare, Laura Chiodini, Paolo Gallo, Ciro |
| author_sort | Perrone, Francesco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8529863 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85298632021-10-22 Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial Perrone, Francesco Piccirillo, Maria Carmela Ascierto, Paolo Antonio Salvarani, Carlo Parrella, Roberto Marata, Anna Maria Popoli, Patrizia Ferraris, Laurenzia Marrocco-Trischitta, Massimiliano M. Ripamonti, Diego Binda, Francesca Bonfanti, Paolo Squillace, Nicola Castelli, Francesco Muiesan, Maria Lorenza Lichtner, Miriam Calzetti, Carlo Salerno, Nicola Duccio Atripaldi, Luigi Cascella, Marco Costantini, Massimo Dolci, Giovanni Facciolongo, Nicola Cosimo Fraganza, Fiorentino Massari, Marco Montesarchio, Vincenzo Mussini, Cristina Negri, Emanuele Alberto Botti, Gerardo Cardone, Claudia Gargiulo, Piera Gravina, Adriano Schettino, Clorinda Arenare, Laura Chiodini, Paolo Gallo, Ciro J Transl Med Correction BioMed Central 2021-10-21 /pmc/articles/PMC8529863/ /pubmed/34674735 http://dx.doi.org/10.1186/s12967-021-03094-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Perrone, Francesco Piccirillo, Maria Carmela Ascierto, Paolo Antonio Salvarani, Carlo Parrella, Roberto Marata, Anna Maria Popoli, Patrizia Ferraris, Laurenzia Marrocco-Trischitta, Massimiliano M. Ripamonti, Diego Binda, Francesca Bonfanti, Paolo Squillace, Nicola Castelli, Francesco Muiesan, Maria Lorenza Lichtner, Miriam Calzetti, Carlo Salerno, Nicola Duccio Atripaldi, Luigi Cascella, Marco Costantini, Massimo Dolci, Giovanni Facciolongo, Nicola Cosimo Fraganza, Fiorentino Massari, Marco Montesarchio, Vincenzo Mussini, Cristina Negri, Emanuele Alberto Botti, Gerardo Cardone, Claudia Gargiulo, Piera Gravina, Adriano Schettino, Clorinda Arenare, Laura Chiodini, Paolo Gallo, Ciro Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
| title | Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
| title_full | Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
| title_fullStr | Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
| title_full_unstemmed | Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
| title_short | Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial |
| title_sort | correction to: tocilizumab for patients with covid-19 pneumonia. the single-arm tocivid-19 prospective trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529863/ https://www.ncbi.nlm.nih.gov/pubmed/34674735 http://dx.doi.org/10.1186/s12967-021-03094-9 |
| work_keys_str_mv | AT perronefrancesco correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT piccirillomariacarmela correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT asciertopaoloantonio correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT salvaranicarlo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT parrellaroberto correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT marataannamaria correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT popolipatrizia correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT ferrarislaurenzia correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT marroccotrischittamassimilianom correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT ripamontidiego correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT bindafrancesca correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT bonfantipaolo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT squillacenicola correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT castellifrancesco correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT muiesanmarialorenza correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT lichtnermiriam correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT calzetticarlo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT salernonicoladuccio correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT atripaldiluigi correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT cascellamarco correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT costantinimassimo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT dolcigiovanni correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT facciolongonicolacosimo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT fraganzafiorentino correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT massarimarco correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT montesarchiovincenzo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT mussinicristina correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT negriemanuelealberto correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT bottigerardo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT cardoneclaudia correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT gargiulopiera correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT gravinaadriano correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT schettinoclorinda correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT arenarelaura correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT chiodinipaolo correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT gallociro correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial AT correctiontotocilizumabforpatientswithcovid19pneumoniathesinglearmtocivid19prospectivetrial |